Potential role of lactylation in intrinsic immune pathways in lung cancer

Lung cancer, one of the most lethal malignancies, has seen its therapeutic strategies become a focal point of significant scientific attention. Intrinsic immune signaling pathways play crucial roles in anti-tumor immunity but face clinical application challenges despite promising preclinical outcome...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengdie Huang, Ye Jin, Dandan Zhao, Xingren Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1533493/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850038553124274176
author Mengdie Huang
Ye Jin
Dandan Zhao
Xingren Liu
author_facet Mengdie Huang
Ye Jin
Dandan Zhao
Xingren Liu
author_sort Mengdie Huang
collection DOAJ
description Lung cancer, one of the most lethal malignancies, has seen its therapeutic strategies become a focal point of significant scientific attention. Intrinsic immune signaling pathways play crucial roles in anti-tumor immunity but face clinical application challenges despite promising preclinical outcomes. Lactylation, an emerging research focus, may influences lung cancer progression by modulating the functions of histones and non-histone proteins. Recent findings have suggested that lactylation regulates key intrinsic immune molecules, including cGAS-STING, TLR, and RIG-I, thereby impacting interferon expression. However, the precise mechanisms by which lactylation governs intrinsic immune signaling in lung cancer remain unclear. This review presents a comprehensive and systematic analysis of the relationship between lactylation and intrinsic immune signaling pathways in lung cancer and emphasizes the innovative perspective of linking lactylation-mediated epigenetic modifications with immune regulation. By thoroughly examining current research findings, this review uncovers potential regulatory mechanisms and highlights the therapeutic implications of targeting lactylation in lung cancer. Future investigations into the intricate interactions between lactylation and intrinsic immunity are anticipated to unveil novel therapeutic targets and strategies, potentially improving patient survival outcomes.
format Article
id doaj-art-b6b23ed38dda49edabbfd677122d5c5e
institution DOAJ
issn 1663-9812
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-b6b23ed38dda49edabbfd677122d5c5e2025-08-20T02:56:33ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-03-011610.3389/fphar.2025.15334931533493Potential role of lactylation in intrinsic immune pathways in lung cancerMengdie Huang0Ye Jin1Dandan Zhao2Xingren Liu3Department of Pulmonary and Critical Care Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pulmonary and Critical Care Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Thoracic Surgery, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Pulmonary and Critical Care Medicine, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaLung cancer, one of the most lethal malignancies, has seen its therapeutic strategies become a focal point of significant scientific attention. Intrinsic immune signaling pathways play crucial roles in anti-tumor immunity but face clinical application challenges despite promising preclinical outcomes. Lactylation, an emerging research focus, may influences lung cancer progression by modulating the functions of histones and non-histone proteins. Recent findings have suggested that lactylation regulates key intrinsic immune molecules, including cGAS-STING, TLR, and RIG-I, thereby impacting interferon expression. However, the precise mechanisms by which lactylation governs intrinsic immune signaling in lung cancer remain unclear. This review presents a comprehensive and systematic analysis of the relationship between lactylation and intrinsic immune signaling pathways in lung cancer and emphasizes the innovative perspective of linking lactylation-mediated epigenetic modifications with immune regulation. By thoroughly examining current research findings, this review uncovers potential regulatory mechanisms and highlights the therapeutic implications of targeting lactylation in lung cancer. Future investigations into the intricate interactions between lactylation and intrinsic immunity are anticipated to unveil novel therapeutic targets and strategies, potentially improving patient survival outcomes.https://www.frontiersin.org/articles/10.3389/fphar.2025.1533493/fulllactylationcGAS-STINGTLRRIG-Ilung cance
spellingShingle Mengdie Huang
Ye Jin
Dandan Zhao
Xingren Liu
Potential role of lactylation in intrinsic immune pathways in lung cancer
Frontiers in Pharmacology
lactylation
cGAS-STING
TLR
RIG-I
lung cance
title Potential role of lactylation in intrinsic immune pathways in lung cancer
title_full Potential role of lactylation in intrinsic immune pathways in lung cancer
title_fullStr Potential role of lactylation in intrinsic immune pathways in lung cancer
title_full_unstemmed Potential role of lactylation in intrinsic immune pathways in lung cancer
title_short Potential role of lactylation in intrinsic immune pathways in lung cancer
title_sort potential role of lactylation in intrinsic immune pathways in lung cancer
topic lactylation
cGAS-STING
TLR
RIG-I
lung cance
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1533493/full
work_keys_str_mv AT mengdiehuang potentialroleoflactylationinintrinsicimmunepathwaysinlungcancer
AT yejin potentialroleoflactylationinintrinsicimmunepathwaysinlungcancer
AT dandanzhao potentialroleoflactylationinintrinsicimmunepathwaysinlungcancer
AT xingrenliu potentialroleoflactylationinintrinsicimmunepathwaysinlungcancer